288 related articles for article (PubMed ID: 26314958)
1. Tolerance and dose-volume relationship of intrathoracic stomach irradiation after esophagectomy for patients with thoracic esophageal squamous cell carcinoma.
Liu Q; Cai XW; Fu XL; Chen JC; Xiang JQ
Oncotarget; 2015 Oct; 6(31):32220-7. PubMed ID: 26314958
[TBL] [Abstract][Full Text] [Related]
2. High dose radiation with chemotherapy followed by salvage esophagectomy among patients with locally advanced esophageal squamous cell carcinoma.
Lertbutsayanukul C; Tharavej C; Klaikeaw N; Prayongrat A; Lowanitchai C; Sriuranpong V
Thorac Cancer; 2017 May; 8(3):219-228. PubMed ID: 28322515
[TBL] [Abstract][Full Text] [Related]
3. Preoperative low-dose weekly cisplatin and continuous infusion fluorouracil plus hyperfractionated radiotherapy in stage II-III esophageal carcinoma.
Caro M; Font A; Comas S; Viciano M; Remon J; Céliz P; Robles J; Musulén E; Sendrós MJ; Mesalles E; Jiménez JA; Boix J; Arellano A; Fernández-Llamazares J
Clin Transl Oncol; 2016 Nov; 18(11):1106-1113. PubMed ID: 26856597
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
5. Tolerance of organs at risk in small-volume, hypofractionated, image-guided radiotherapy for primary and metastatic lung cancers.
Onimaru R; Shirato H; Shimizu S; Kitamura K; Xu B; Fukumoto S; Chang TC; Fujita K; Oita M; Miyasaka K; Nishimura M; Dosaka-Akita H
Int J Radiat Oncol Biol Phys; 2003 May; 56(1):126-35. PubMed ID: 12694831
[TBL] [Abstract][Full Text] [Related]
6. Clinical and dosimetric predictors of radiation-induced esophageal toxicity.
Maguire PD; Sibley GS; Zhou SM; Jamieson TA; Light KL; Antoine PA; Herndon JE; Anscher MS; Marks LB
Int J Radiat Oncol Biol Phys; 1999 Aug; 45(1):97-103. PubMed ID: 10477012
[TBL] [Abstract][Full Text] [Related]
7. Positive impact of radiation dose on disease free survival and locoregional control in postoperative radiotherapy for squamous cell carcinoma of esophagus.
Moon S; Kim H; Chie E; Kim J; Park C
Dis Esophagus; 2009; 22(4):298-304. PubMed ID: 19021683
[TBL] [Abstract][Full Text] [Related]
8. Dosimetric and clinical predictors of radiation-induced lung toxicity in esophageal carcinoma.
Zhu SC; Shen WB; Liu ZK; Li J; Su JW; Wang YX
Tumori; 2011; 97(5):596-602. PubMed ID: 22158490
[TBL] [Abstract][Full Text] [Related]
9. Dosimetric Predictors of Radiation Gastritis Due to Postoperative Intensity Modulated Irradiation Therapy in Patients with Esophageal Squamous Cell Carcinoma After Radical Esophagectomy.
Shen WB; Wang YF; Gao HM; Zhu SC; Li YM; Li SG; Su JW; Li J; Liu ZK
Cancer Biother Radiopharm; 2019 Sep; 34(7):419-426. PubMed ID: 31149837
[No Abstract] [Full Text] [Related]
10. Postoperative pulmonary complications after preoperative chemoradiation for esophageal carcinoma: correlation with pulmonary dose-volume histogram parameters.
Lee HK; Vaporciyan AA; Cox JD; Tucker SL; Putnam JB; Ajani JA; Liao Z; Swisher SG; Roth JA; Smythe WR; Walsh GL; Mohan R; Liu HH; Mooring D; Komaki R
Int J Radiat Oncol Biol Phys; 2003 Dec; 57(5):1317-22. PubMed ID: 14630268
[TBL] [Abstract][Full Text] [Related]
11. Intrathoracic gastric emptying of solid food after esophagectomy for esophageal cancer.
Lee HS; Kim MS; Lee JM; Kim SK; Kang KW; Zo JI
Ann Thorac Surg; 2005 Aug; 80(2):443-7. PubMed ID: 16039182
[TBL] [Abstract][Full Text] [Related]
12. Clinical study of modified Ivor-Lewis esophagectomy plus adjuvant radiotherapy for local control of stage IIA squamous cell carcinoma in the mid-thoracic esophagus.
Chen G; Wang Z; Liu XY; Zhang MY; Liu FY
Eur J Cardiothorac Surg; 2009 Jan; 35(1):1-7. PubMed ID: 18926712
[TBL] [Abstract][Full Text] [Related]
13. Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma.
Bradley J; Graham MV; Winter K; Purdy JA; Komaki R; Roa WH; Ryu JK; Bosch W; Emami B
Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):318-28. PubMed ID: 15667949
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of esophagectomy in patients with thoracic esophageal squamous cell carcinoma receiving definitive radiotherapy or concurrent chemoradiotherapy through intensity-modulated radiation therapy techniques.
Yen YC; Chang JH; Lin WC; Chiou JF; Chang YC; Chang CL; Hsu HL; Chow JM; Yuan KS; Wu ATH; Wu SY
Cancer; 2017 Jun; 123(11):2043-2053. PubMed ID: 28152166
[TBL] [Abstract][Full Text] [Related]
15. [Patterns of recurrence in patients with stage Ⅲ thoracic esophageal squamous cell carcinoma after radical resection].
Wang YX; Yang Q; He M; Qiu R; Li J; Zhu SC; Qiao XY; Qi Z
Zhonghua Zhong Liu Za Zhi; 2017 Jan; 39(1):48-55. PubMed ID: 28104034
[No Abstract] [Full Text] [Related]
16. Distribution of lymph node metastasis and clinical validity of gastric tube reconstruction in lower thoracic esophageal squamous cell carcinoma with gastric invasion.
Matsuda S; Tsubosa Y; Niihara M; Sato H; Takebayashi K; Kawamorita K; Mori K; Tsushima T; Yasui H; Takeuchi H; Kitagawa Y
Ann Surg Oncol; 2015 Feb; 22(2):617-23. PubMed ID: 25164036
[TBL] [Abstract][Full Text] [Related]
17. Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapy.
Vargas C; Martinez A; Kestin LL; Yan D; Grills I; Brabbins DS; Lockman DM; Liang J; Gustafson GS; Chen PY; Vicini FA; Wong JW
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1297-308. PubMed ID: 16029785
[TBL] [Abstract][Full Text] [Related]
18. Morphologic alterations in esophageal squamous cell carcinoma after preoperative high dose rate intraluminal brachytherapy.
Sur M; Sur R; Cooper K; Levin V; Bizos D; Dubazana N
Cancer; 1996 Jun; 77(11):2200-5. PubMed ID: 8635084
[TBL] [Abstract][Full Text] [Related]
19. Risk of radiation pneumonitis in patients receiving taxane-based trimodality therapy for locally advanced esophageal cancer.
Shaikh T; Churilla TM; Monpara P; Scott WJ; Cohen SJ; Meyer JE
Pract Radiat Oncol; 2016; 6(6):388-394. PubMed ID: 27025161
[TBL] [Abstract][Full Text] [Related]
20. The status of perineural invasion predicts the outcomes of postoperative radiotherapy in locally advanced esophageal squamous cell carcinoma.
Ning ZH; Zhao W; Li XD; Chen LJ; Xu B; Gu WD; Shao YJ; Xu Y; Huang J; Pei HL; Jiang JT
Int J Clin Exp Pathol; 2015; 8(6):6881-90. PubMed ID: 26261575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
